6.17MMarket Cap-1500P/E (Static)
0.003High0.003Low808.45KVolume0.003Open0.004Pre Close2.43KTurnover0.01152wk High0.06%Turnover Ratio2.06BShares0.00352wk Low-0.002EPS TTM4.21MFloat Cap0.619Historical HighLossP/E (Static)1.40BShs Float0.003Historical Low-0.002EPS LYR0.00%Amplitude--Dividend TTM1.50P/B1Lot Size--Div YieldTTM
Patrys Ltd Stock Forum
Delivery of GENE-EDITING constructs could be very lucrative for PAB . Something not priced in the share price regarding future potential.
Comment by PAB in 2022
Patrys could also become a pioneer in the emerging gene-editing
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.
No comment yet